MiR-302c-3p suppresses invasion and proliferation of glioma cells via down-regulating metadherin (MTDH) expression

References

• Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008; 359: 492-507; PMID:18669428; http://dx.doi.org/10.1056/NEJMra0708126
   PubMed Web of Science ®Google Scholar
• Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, Lamborn KR, Berger MS, Botstein D, Brown PO, et al. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A 2005; 102:5814-9; PMID:15827123; http://dx.doi.org/10.1073/pnas.0402870102
   PubMed Web of Science ®Google Scholar
• van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 2011; 11:644-56; PMID:21822212; http://dx.doi.org/10.1038/nrc3107
   PubMed Web of Science ®Google Scholar
• Petrocca F, Lieberman J. Promise and challenge of RNA interference-based therapy for cancer. J Clin Oncol 2011; 29:747-54; PMID:21079135; http://dx.doi.org/10.1200/JCO.2009.27.6287
   PubMed Web of Science ®Google Scholar
• Kwak PB, Iwasaki S, Tomari Y. The microRNA pathway and cancer. Cancer Sci 2010; 101:2309-15; PMID:20726859; http://dx.doi.org/10.1111/j.1349-7006.2010.01683.x
   PubMed Web of Science ®Google Scholar
• Liu X, Li G, Su Z, Jiang Z, Chen L, Wang J, Yu S, Liu Z. Poly(amido amine) is an ideal carrier of miR-7 for enhancing gene silencing effects on the EGFR pathway in U251 glioma cells. Oncol Rep 2013; 29:1387-94; PMID:23404538
   PubMed Web of Science ®Google Scholar
• Lu ZJ, Liu SY, Yao YQ, Zhou YJ, Zhang S, Dai L, Tian HW, Zhou Y, Deng HX, Yang JL, et al. The effect of miR-7 on behavior and global protein expression in glioma cell lines. Electrophoresis 2011; 32:3612-20; PMID:22120825; http://dx.doi.org/10.1002/elps.201100230
   PubMed Web of Science ®Google Scholar
• Shi Z, Chen Q, Li C, Wang L, Qian X, Jiang C, Liu X, Wang X, Li H, Kang C, et al. MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras. Neuro Oncol 2014; 16:1341-53; PMID:24861879; http://dx.doi.org/10.1093/neuonc/nou084
   PubMed Web of Science ®Google Scholar
• Li A, Lin X, Tan X, Yin B, Han W, Zhao J, Yuan J, Qiang B, Peng X. Circadian gene Clock contributes to cell proliferation and migration of glioma and is directly regulated by tumor-suppressive miR-124. FEBS Lett 2013; 587:2455-60; PMID:23792158; http://dx.doi.org/10.1016/j.febslet.2013.06.018
   PubMed Web of Science ®Google Scholar
• Wei J, Wang F, Kong LY, Xu S, Doucette T, Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O, et al. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res 2013; 73:3913-26; PMID:23636127; http://dx.doi.org/10.1158/0008-5472.CAN-12-4318
   PubMed Web of Science ®Google Scholar
• Papagiannakopoulos T, Friedmann-Morvinski D, Neveu P, Dugas JC, Gill RM, Huillard E, Liu C, Zong H, Rowitch DH, Barres BA, et al. Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene 2012; 31:1884-95; PMID:21874051; http://dx.doi.org/10.1038/onc.2011.380
   PubMed Web of Science ®Google Scholar
• Ji Y, Wei Y, Wang J, Ao Q, Gong K, Zuo H. Decreased expression of microRNA-107 predicts poorer prognosis in glioma. Tumour Biol 2015; PMID:25596705; http://dx.doi.org/10.1007/s13277-015-3086-y
   PubMed Web of Science ®Google Scholar
• Sun YC, Wang J, Guo CC, Sai K, Wang J, Chen FR, Yang QY, Chen YS, Wang J, To TS, et al. MiR-181b sensitizes glioma cells to teniposide by targeting MDM2. BMC Cancer 2014; 14:611; PMID:25151861; http://dx.doi.org/10.1186/1471-2407-14-611
   PubMed Web of Science ®Google Scholar
• Wang J, Sai K, Chen FR, Chen ZP. miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1. Cancer Chemother Pharmacol 2013; 72:147-58; PMID:23645289; http://dx.doi.org/10.1007/s00280-013-2180-3
   PubMed Web of Science ®Google Scholar
• Li P, Lu X, Wang Y, Sun L, Qian C, Yan W, Liu N, You Y, Fu Z. MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells. J Biomed Res 2010; 24:436-43; PMID:23554660; http://dx.doi.org/10.1016/S1674-8301(10)60058-9
   PubMedGoogle Scholar
• Min D, Lv XB, Wang X, Zhang B, Meng W, Yu F, Hu H. Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity. Br J Cancer 2013; 109:723-30; PMID:23820258; http://dx.doi.org/10.1038/bjc.2013.337
   PubMed Web of Science ®Google Scholar
• O'day E, Lal A. MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res 2010; 12; PMID:20346098; http://dx.doi.org/10.1186/bcr2484
   PubMed Web of Science ®Google Scholar
• Zhu K, Pan Q, Jia LQ, Dai Z, Ke AW, Zeng HY, Tang ZY, Fan J, Zhou J. MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells. Sci Rep 2014; 4:5524; PMID:25027009
   PubMed Web of Science ®Google Scholar
• Fareh M, Turchi L, Virolle V, Debruyne D, Almairac F, de-la-Forest Divonne S, Paquis P, Preynat-Seauve O, Krause KH, Chneiweiss H, et al. The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell Death Differ 2012; 19:232-44; PMID:21720384; http://dx.doi.org/10.1038/cdd.2011.89
   PubMed Web of Science ®Google Scholar
• Froklage FE, Oosterbaan LJ, Sizoo EM, de Groot M, Bosma I, Sanchez E, Douw L, Heimans JJ, Reijneveld JC, Lagerwaard FJ, et al. Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study. J Neurooncol 2014; 116:387-94; PMID:24264531; http://dx.doi.org/10.1007/s11060-013-1310-4
   PubMed Web of Science ®Google Scholar
• Khan UA, Bhavsar A, Asif H, Karabatsou K, Leggate JR, Sofat A, Kamaly-Asl ID. Treatment by specialist surgical neurooncologists improves survival times for patients with malignant glioma. J Neurosurg 2015; 122:297-302; PMID:25415070; http://dx.doi.org/10.3171/2014.10.JNS132057
   PubMed Web of Science ®Google Scholar
• He H, Hao SJ, Yao L, Yang F, Di Y, Li J, Jiang YJ, Jin C, Fu DL. MicroRNA-218 inhibits cell invasion and migration of pancreatic cancer via regulating ROBO1. Cancer Biol Ther 2014; 15:1333-9; PMID:25010661; http://dx.doi.org/10.4161/cbt.29706
   PubMed Web of Science ®Google Scholar
• Huang Y, Li LP. Progress of cancer research on astrocyte elevated gene-1/Metadherin (Review). Oncol Lett 2014; 8:493-501; PMID:25009642
   PubMed Web of Science ®Google Scholar
• Lee SG, Kim K, Kegelman TP, Dash R, Das SK, Choi JK, Emdad L, Howlett EL, Jeon HY, Su ZZ, et al. Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicity. Cancer research 2011; 71:6514-23; PMID:21852380; http://dx.doi.org/10.1158/0008-5472.CAN-11-0782
   PubMed Web of Science ®Google Scholar
• Lee SG, Su ZZ, Emdad L, Sarkar D, Fisher PB. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci U S A 2006; 103:17390-5; PMID:17088530; http://dx.doi.org/10.1073/pnas.0608386103
   PubMed Web of Science ®Google Scholar
• Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF, Fisher PB. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 2008; 27:1114-21; PMID:17704808; http://dx.doi.org/10.1038/sj.onc.1210713
   PubMed Web of Science ®Google Scholar
• Emdad L, Lee SG, Su ZZ, Jeon HY, Boukerche H, Sarkar D, Fisher PB. Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc Natl Acad Sci U S A 2009; 106:21300-5; PMID:19940250; http://dx.doi.org/10.1073/pnas.0910936106
   PubMed Web of Science ®Google Scholar
• Yoo BK, Chen D, Su ZZ, Gredler R, Yoo J, Shah K, Fisher PB, Sarkar D. Molecular mechanism of chemoresistance by astrocyte elevated gene-1. Cancer Res 2010; 70:3249-58; PMID:20388796; http://dx.doi.org/10.1158/0008-5472.CAN-09-4009
   PubMed Web of Science ®Google Scholar
• Emdad L, Sarkar D, Lee SG, Su ZZ, Yoo BK, Dash R, Yacoub A, Fuller CE, Shah K, Dent P, et al. Astrocyte elevated gene-1: a novel target for human glioma therapy. Mol Cancer Ther 2010; 9:79-88; PMID:20053777; http://dx.doi.org/10.1158/1535-7163.MCT-09-0752
   PubMed Web of Science ®Google Scholar
• Noch E, Bookland M, Khalili K. Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose deprivation in glioblastoma. Cancer Biol Ther 2014; 11:32-9; PMID:21084864; http://dx.doi.org/10.4161/cbt.11.1.13835
   PubMed Web of Science ®Google Scholar
• Baumann BC, Dorsey JF. Astrocyte-elevated gene-1 (AEG-1): Glioblastoma's helping hand during times of hypoxia and glucose deprivation? Cancer Biol Ther 2014; 11:40-2; PMID:21150314; http://dx.doi.org/10.4161/cbt.11.1.14139
   PubMed Web of Science ®Google Scholar